← FDA Drug Approvals (Drugs@FDA)

RANOLAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2021-03-11

Drug application

FDA Application #

ANDA207690

Application type

Abbreviated New Drug Application (Generic)

Brand name

RANOLAZINE

Generic name

Ranolazine

Active ingredients

RANOLAZINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

AMNEAL

First approval

2021-03-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown